Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biovotion

Explore full profile

Wearable physiology monitoring company

London, United KingdomFounded 2011Biotech & Life Sciences
Valuation $50–100M Last recorded · 2017
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biovotion and the history behind them.

About Biovotion

Biovotion, founded in Zurich, Switzerland, in 2011, specialized in wearable physiology monitoring, providing integrated solutions that included connected hardware and value-added services. The company was established by Dr. Andreas Caduff, an expert in non-invasive, wearable sensor technologies with a background in the pharmaceutical and medical device industries. His work focused on developing multisensor systems for wearable physiological monitoring, driven by the potential he saw in combining these devices with software ecosystems and machine learning.

Read full description

The firm developed the Everion®, a clinical-grade, multi-sensor wearable device worn on the arm. This platform was designed to non-invasively measure 22 different parameters in real-time, such as heart rate, respiratory rate, blood oxygenation, and skin temperature. It also captured insights into sleep quality, energy expenditure, and stress levels. The data collected by the Everion device was integrated into a cloud platform, providing users with health data comparable to standard hospital monitoring systems. Biovotion's business model was centered on this combination of hardware, software, and services, forming a hybrid offering for continuous health monitoring both in clinical settings and at home. The company's clients included pharmaceutical companies, contract research organizations, and healthcare providers like the Mayo Clinic and the University Hospital of Basel.

A significant milestone in the company's history occurred in November 2019, when it was acquired by Biofourmis, a Boston-based digital therapeutics company. The acquisition included Biovotion's entire portfolio, featuring the Everion biosensor and over 60 global patents for wearable sensor technology. Following the acquisition, the Biovotion team was integrated into Biofourmis, operating under the new name Biofourmis AG in Zurich. This strategic move allowed Biofourmis to incorporate Biovotion's clinical-grade wearables into its own Biovitals® ecosystem, an AI-powered analytics platform that predicts clinical exacerbations. The integration aimed to create a comprehensive digital therapeutics solution for managing complex chronic conditions like heart failure, COPD, and oncology by combining continuous physiological data with predictive analytics. Keywords: Biovotion, Biofourmis, Everion, wearable physiology monitoring, digital health, medical-grade wearable, remote patient monitoring, biosensor, vital sign monitoring, Andreas Caduff, continuous monitoring, healthcare technology, clinical-grade sensor, digital therapeutics, physiological data, health analytics, chronic disease management, non-invasive monitoring, wearable sensor technology, AI health analytics, connected health, Biovitals, remote monitoring solutions

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2011
Headquarters
London, United Kingdom
Employees
1
Open positions
None listed
Dealroom signal
60.6/100
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Diabetes
Technology
Artificial Intelligence, Hardware, Big Data, Deep Tech, Machine Learning, Computer Vision, Connected Device, IoT InternetOfThings
Business model
Manufacturing, Marketplace & ecommerce
Client focus
b2c

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Nov 2019 $0 — Biofourmis —
SERIES A✓Equity / VC Jul 2017 $13M $50M Swiss RE · Harmony Medical Inc · STMicroelectronics ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Biovotion website traffic

Latest recorded traffic for Biovotion is 220 monthly website visits, up 22.2% over the last three months. Biovotion's team grew 0% over the past year.

Latest monthly visits220 3-month web change+22.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Swiss RE
  • STMicroelectronics
  • Harmony Medical Inc

Other known investors1 additional known investor

  • Biofourmis
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · London HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Biovotion on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biovotion’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.